The Decongestant on Your Shelf May Not Work — Here's What the FDA Found

By Charlene Hope, PharmD, MS  |  July 14, 2026

You reach for the cold medicine you've trusted for years — the one sitting right there on the shelf — and assume it will clear your congestion. But what if it doesn't actually work? That's not a hypothetical. In 2023, an FDA advisory committee made a unanimous ruling that sent shockwaves through the cold and allergy aisle, and most people still haven't heard about it.

What Is Phenylephrine — and Why Is It Everywhere?

Phenylephrine (PE) is the oral decongestant found in hundreds of OTC cold products — Sudafed PE, DayQuil, NyQuil Severe, and countless store-brand versions. It became the front-of-shelf standard after 2006, when the Combat Methamphetamine Epidemic Act moved pseudoephedrine (PSE) behind the pharmacy counter to curb its use in illegal drug production.

The logic was sound from a regulatory standpoint. The problem? The science didn't keep up. As PE flooded the market, researchers began questioning whether the dose approved for oral use actually reached the nasal passages in meaningful amounts — and the answer turned out to be largely no.

What the FDA Actually Ruled

In September 2023, the FDA's Nonprescription Drugs Advisory Committee voted unanimously — 16 to 0 — that oral phenylephrine is not effective as a nasal decongestant. The FDA followed up in 2024 by formally proposing to withdraw its GRASE (Generally Recognized As Safe and Effective) status for oral PE. That means the agency is moving toward pulling the ingredient's approval for this use entirely.

Products are still on shelves while the regulatory process plays out — but the scientific consensus is clear. If you've been taking PE-containing products for congestion and wondering why you still can't breathe, now you know.

So What Does Actually Work?

The good news: there are evidence-backed options. Here is what pharmacists actually recommend:

Pseudoephedrine (PSE): Products like original Sudafed, kept behind the pharmacy counter, contain PSE and have solid clinical evidence behind them. Yes, you have to show an ID and sign a log — but the extra step is worth it for real relief.

Oxymetazoline (Afrin, generic nasal sprays): Topical nasal decongestants work directly where you need them and are fast-acting. But limit use to 3 days or less. Longer use causes rebound congestion (rhinitis medicamentosa) — where stopping the spray makes your nose more stuffed than before you started.

Check Your Labels Before You Buy

Combination cold products are tricky because they bundle multiple active ingredients together. A product marketed for "cold and flu" might include PE for congestion alongside other ingredients that do work — like acetaminophen for fever or dextromethorphan for cough. Reading the Drug Facts label carefully is the only way to know what you're actually getting.

If the only active decongestant listed is phenylephrine HCl, consider asking your pharmacist about an alternative. The FDA ruling doesn't mean these products are dangerous — it means the decongestant component is likely not doing what the label implies.

Your Pharmacist Is the Expert in That Aisle

T

his is exactly the kind of "why didn't anyone tell me?" situation that your pharmacist is trained for. Before you grab the first familiar box, just ask. A pharmacist can look at your health history, current medications, and symptoms to point you toward what will actually help — without wasting your money on something that won't.

The cold and allergy aisle has never been more confusing. But you don't have to navigate it alone.